Trimethoprim–sulfamethoxazole susceptibility in beta-hemolytic streptococci in a Canadian tertiary center

Simple item page
dc.contributor.authorAriane Gendron
dc.contributor.authorRachel Higgins
dc.contributor.authorSimon Lévesque
dc.contributor.authorNathalie Brown
dc.contributor.authorEve Capistran
dc.contributor.authorVincent Masse
dc.contributor.authorPhilippe Martin
dc.date.accessioned2026-05-19T08:33:36Z
dc.date.issued2026-9
dc.identifier.doi10.1016/j.diagmicrobio.2026.117439
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/12683
dc.identifier.uri.pubmedhttps://doi.org/10.1016/j.diagmicrobio.2026.117439
dc.sourceDiagnostic Microbiology and Infectious Disease
dc.titleTrimethoprim–sulfamethoxazole susceptibility in beta-hemolytic streptococci in a Canadian tertiary center

Files

Collections

Published